Reintroduction of O followed by incremental buy-in by Takeda climaxing in a buyout. Timeframe = ~ 2 years.
Justification for opinion: Reintroducing of O will allow the sp to climb on its own merits, Takeda could assist sp escalation by authorizing the buying of so many shares per quarter and at some point a buyout at premium. This, I believe, will keep other suitors at bay and assure stockholders get a reasonable buyout price. Takeda in the meantime continues to market O and to evaluate any incidents that may need further attention. This is a way of having arm's length protection until T is satisfied that all is progressing smoothly. This process can be accelerated but I do not see it being drawn out. Jim
Sentiment: Strong Buy
Jim. That would b premium!!! But ya im hoping for buyout soon since i think thats wuts happening. Then im moving into the next biotech. Im in NVIV but wen affy is done nviv shud b starting to take off
If its a buyout, my personal opinion is it wont be more than $5-$6/share.....
As for reintroducing the drug to the market, its Takeda's show all the way.... they will need to dissolve AFFY in some way....no point in keeping AFFY unless they rebuild a team within AFFY....
Reintroduce to market. I would love to receive 100% + per year dividend on my initial investment, not to mention the increase in share price. But, like Maxdaddy said a buyout is the most likely scenario....
Buyout would be a much faster way to get a return on investment. My choice if the offer is $20.00 per share or more .If Reintroduced,you would have to guess the high of the short squeeze and time it accordingly.
Tsmith was the first person to read my mind. Congrates. Im seeing buyout around 4$. Im in till that happens n then moving on. Iv never been in a stock not moving for this long but im wayyyy too deep to move on until something happens. Hoping within 2 months. IMHO